Management of Autism Spectrum Disorder with Propranolol

Introduction to Propranolol Dosage

The American Academy of Child and Adolescent Psychiatry recommends an initial propranolol dose of 0.5-1 mg/kg/day for individuals with severe autism spectrum disorder (ASD), with a target maintenance dose of 1-3 mg/kg/day divided into 2-3 daily doses, based on symptom response and tolerability 1
The starting dose should be 0.5-1 mg/kg/day divided into 2-3 doses, according to the American Academy of Child and Adolescent Psychiatry 1
For patients with comorbidities or risk factors for hypoglycemia, the dose should be started at the lower end (0.5 mg/kg/day)

The dose should be increased gradually at minimum intervals of 24 hours, as recommended by the British Journal of Dermatology 2
The dose should be titrated to a target dose of 1-3 mg/kg/day based on symptom control, with a maximum dose for non-responders of 3 mg/kg/day, according to the British Journal of Dermatology 2
Monitoring for clinical response and side effects is essential, with follow-up visits every 2-3 months for stable patients, as recommended by the British Journal of Dermatology 2

Propranolol has demonstrated efficacy for hyperactivity, with significant reduction in hyperactivity with doses of 0.5-1 mg/kg/day, according to the American Academy of Child and Adolescent Psychiatry 1
Propranolol has shown a positive trend for improvement in self-injurious behavior, with doses of 0.5-1 mg/kg/day, as recommended by the American Academy of Child and Adolescent Psychiatry 1

Transient sedation, decreased heart rate and blood pressure, and potential for increased aggression and stereotypy in some patients are possible side effects of propranolol, according to the American Academy of Child and Adolescent Psychiatry 1
Hypoglycemic episodes, second or third-degree heart block, hypersensitivity to propranolol, and blood pressure or heart rate outside normal range for age are contraindications for propranolol use, as recommended by the British Journal of Dermatology 2

Propranolol can be safely discontinued abruptly rather than requiring gradual tapering, according to the British Journal of Dermatology 2
Propranolol should be used with caution in patients with cardiac risk factors, and an ECG should be considered in these patients, as recommended by the British Journal of Dermatology 2